profit from every R$100 of sales.
R$0R$100
Bradsaúde
R$16.43+0.86% today
+23.7% in 1 year
1-year low R$10.511-year high R$16.55
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay R$82.45 for every R$1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Bradsaúde sold, what it kept, and what it did with the cash.
Sales went from R$1.85 billion in 2022 to R$2.42 billion in 2025, with R$583 million of profit last year.
SalesProfit
Bradsaúde handed back more cash to shareholders than it generated last year.
R$662M
Free cash flow 2025R$505M
Bought back its own sharesR$15M
Paid as dividendsR$662M
Cash vs. debtR$20M vs. R$21M
Bradsaúde vs. similar companies
Bradsaúde grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from R$100 of sales | Sales growth a year | Price per R$1 of profit |
|---|---|---|---|
| Bradsaúde | 82.4× · Very expensive | ||
 UnitedHealth | 30.3× · Expensive | ||
 CVS Health | 64.7× · Very expensive | ||
 Elevance Health | 16.4× · Fair price | ||
 The Cigna Group | 13.1× · Cheap |
AI analysis
An AI analyst reads Bradsaúde's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,854 | 2,119 | 2,281 | 2,420 | |
| 501 | 696 | 791 | 870 | |
| 477 | 642 | 682 | 770 | |
| 589 | 1,020 | 1,080 | 1,183 | |
| 366 | 511 | 539 | 583 | |
| 0.66 | 0.93 | 0.99 | 1.07 | |
| 27.0% | 32.9% | 34.7% | 36.0% | |
| 25.7% | 30.3% | 29.9% | 31.8% | |
| 19.7% | 24.1% | 23.6% | 24.1% |
Balance sheet
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1,873 | 2,164 | 2,122 | 1,949 |
| Cash | 16 | 14 | 17 | 20 |
| Total debt | 20 | 31 | 26 | 21 |
| Total liabilities | 744 | 776 | 894 | 667 |
| 1,128 | 1,387 | 1,228 | 1,282 | |
| 553 | 552 | 547 | 545 | |
| 31.7% | 35.3% | 42.1% | 44.2% | |
| 32.4% | 36.9% | 43.9% | 45.4% |
Cash flow
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 695 | 415 | 542 | 590 | |
| 71 | 95 | 93 | 85 | |
| 623 | 319 | 449 | 505 | |
| Dividends paid | 170 | 183 | 543 | 662 |
| 170 | 0 | 69 | 15 | |
| – | – | – | – |
Valuation
- 82.4×
- –
- 4.76
- 32.2×
- 19.8×
- 95.1×
- 40.6×
- 1.1%
- 1.2%
- 1.4%
Profitability
- 36.0%
- 31.8%
- 24.1%
- –
- 44.2%
- 38.3%
- –
- –
- –
- –
Growth
- +9.3%
- +17.3%
- –
- –
- −0.5%
Financial health
- 0.0×
- 0.02
- –
- 20.5×
- 0.80
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 2%of 963
Top 9%of 894
Bottom 12%of 632
Bottom 45%of 908
Bottom 47%of 991
1.4%of the share price, paid each year
On $1,000 invested$14a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
113.7% of its profit
Room to growStretchedMore than it earns: 131.1%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
4/7Passes 4 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
73Pass
Benjamin Graham
40No pass
Philip Fisher
72Pass
Peter Lynch
51No pass
Joel Greenblatt
44No pass
Charlie Munger
84Pass
Terry Smith
78Pass
Questions about Bradsaúde
Is Bradsaúde a good stock to buy?
A strong, very profitable business, priced as if everything goes right. 4 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Bradsaúde AI analysis
What does Bradsaúde do?
Bradsaúde S.A. provides private dental care plans in Brazil. The company operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals. It is in Healthcare Plans, based in Barueri, SP, Brazil, with 1,957 employees.
Does Bradsaúde pay a dividend?
Yes. At today's price the dividend is 1.4% a year, about 114% of its yearly profit. In 2025 it paid out R$662 million in dividends.
Is Bradsaúde stock halal?
No. Bradsaúde does not pass our halal screen: its main business, conventional insurance, is not permitted. How we check
How has Bradsaúde stock done over the past year?
Up 23.7% over the past twelve months, to R$16.43. It traded between R$10.51 and R$16.55, close to its high.
Who are Bradsaúde's competitors?
The largest listed companies in the same industry are UnitedHealth, CVS Health, Elevance Health and The Cigna Group. The peers table on this page compares their profit, growth and price with Bradsaúde's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.